Crypto Startup Worth $1.5B Uses Wall Street Playbook Against Hyperliquid

A $1.5 billion crypto startup is taking on Hyperliquid with a Wall Street playbook
Variational, an onchain derivatives startup valued at $1.5 billion, is pitching a different model for how crypto trading could evolve: less like a crypto-native exchange and more like a traditional brokerage.
The company recently raised $110 million to expand its crypto derivatives platform. Variational says it has processed more than $475 billion in trades since launching in 2025.
At the center of its strategy is a request-for-quote (RFQ) model, where traders request a price and receive quotes directly from a market maker, rather than relying on an exchange-style order book. Dragonfly managing partner Haseeb Qureshi said Variational’s open interest, trading volume, active users, and listed markets have all grown substantially over the past six months, pointing to RFQ as a key driver.
“It’s clear the RFQ model they popularized is working, especially for RWA trading (which is over 50% of their volume),” Qureshi told CoinDesk in an email.
Unlike Hyperliquid’s exchange model, Variational says it uses an in-house market maker to quote prices across more than 590 markets, spanning crypto, stocks, commodities, and indices. The company says traditional assets now account for more than half of its daily trading activity, allowing it to expand product coverage without needing a separate market maker for each market.
The approach does not appear to be pulling users directly out of traditional finance. According to a Variational spokesperson, most demand comes from retail traders who are already active on onchain perpetual futures venues, but are looking for products that have historically been harder to access onchain.
“It’s flow from other crypto venues plus demand for swaps, which have not been possible to access on-chain before,” the spokesperson told CoinDesk.
The growth comes as Hyperliquid continues to attract attention from both crypto traders and Wall Street-linked vehicles. Hyperliquid is a blockchain purpose-built for derivatives trading, with HYPE as its native token.
Goldman Sachs’ first-quarter 2026 13F filing showed a $3.3 million stake in Hyperliquid Strategies, a treasury-style vehicle that holds about 20 million HYPE tokens and is modeled on Strategy’s approach of accumulating a target asset.
Hyperliquid’s token economics have also drawn scrutiny. The system uses trading fees to buy back HYPE through an “Assistance Fund,” which has accumulated a $1.4 billion war chest. Supporters describe the mechanism as efficient, while critics have warned it is “highly reflexive,” relying on continued growth in trading activity to sustain the loop.
In parallel, a corporate transaction is set to deepen institutional access to HYPE. A filing dated Oct. 22 outlined a plan for Nasdaq-listed Sonnet BioTherapeutics to undergo an $888 million reverse merger with Rorschach I LLC to form Hyperliquid Strategies Inc. The new entity would launch with a digital asset treasury including about $583 million in HYPE tokens and a $1 billion facility that could be used for additional token purchases. The filing also warned that capital raising through share issuance could bring enhanced regulatory oversight and significant volatility, and that Sonnet shareholders would be heavily diluted.
Together, the developments highlight two different paths for onchain derivatives. Hyperliquid represents the crypto-native exchange model, while Variational and its backers are betting that the next wave of onchain trading will look more like a brokerage, using market-maker quotes to scale across a wide range of crypto and traditional markets.
